Evidence map›Paper›PMID 34105294›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2021

DDIT3 Directs a Dual Mechanism to Balance Glycolysis and Oxidative Phosphorylation during Glutamine Deprivation.

Mingyue Li, Rick Francis Thorne, Ronghua Shi, Xu Dong Zhang, Jingmin Li, Jingtong Li, Qingyuan Zhang, Mian Wu, Lianxin Liu

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. The dual mechanism of mCell death & disease · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Mingyue LiHeifei National Laboratory for Physical Sciences at the Microscale of USTC, CAS Centre for Excellence in Molecular Cell Science, the First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui, 230027, China.
Rick Francis ThorneTranslational Research Institute, Henan Provincial People's Hospital, School of Clinical Medicine, Henan University, Zhengzhou, Henan, 450003, China.
Ronghua ShiHeifei National Laboratory for Physical Sciences at the Microscale of USTC, CAS Centre for Excellence in Molecular Cell Science, the First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui, 230027, China.
Xu Dong ZhangTranslational Research Institute, Henan Provincial People's Hospital, School of Clinical Medicine, Henan University, Zhengzhou, Henan, 450003, China.
Jingmin LiTranslational Research Institute, Henan Provincial People's Hospital, School of Clinical Medicine, Henan University, Zhengzhou, Henan, 450003, China.
Jingtong LiHarbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150081, China.
Qingyuan ZhangHarbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150081, China.
Mian WuHeifei National Laboratory for Physical Sciences at the Microscale of USTC, CAS Centre for Excellence in Molecular Cell Science, the First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui, 230027, China.ORCID 0000-0002-2714-0500
Lianxin LiuHeifei National Laboratory for Physical Sciences at the Microscale of USTC, CAS Centre for Excellence in Molecular Cell Science, the First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui, 230027, China.
University of Science and Technology of China · CNHarbin Medical University · CNHenan University · CN

Funding

National Key R&D Program of China 2018YFA0107100National Natural Science Foundation of China 31871437National Natural Science Foundation of China 81730074National Natural Science Foundation of China 81820108021National Natural Science Foundation of China 81970153
6 · The paper itself

Abstract

Extracellular glutamine represents an important energy source for many cancer cells and its metabolism is intimately involved in maintaining redox homeostasis. The heightened metabolic activity within tumor tissues can result in glutamine deficiency, necessitating metabolic reprogramming responses. Here, dual mechanisms involving the stress-responsive transcription factor DDIT3 (DNA damage induced transcript 3) that establishes an interrelationship between glycolysis and mitochondrial respiration are revealed. DDIT3 is induced during glutamine deprivation to promote glycolysis and adenosine triphosphate production via suppression of the negative glycolytic regulator TIGAR. In concert, a proportion of the DDIT3 pool translocates to the mitochondria and suppresses oxidative phosphorylation through LONP1-mediated down-regulation of COQ9 and COX4. This in turn dampens the sustained levels of reactive oxygen species that follow glutamine withdrawal. Together these mechanisms constitute an adaptive survival mechanism permitting tumor cells to survive metabolic stress induced by glutamine starvation.

Indexed as

AnimalsApoptosis Regulatory ProteinsElectron Transport Complex IVEnergy MetabolismGene Expression Regulation, NeoplasticGlutamineGlycolysisHCT116 CellsHumansMiceMice, KnockoutNeoplasmsOxidative PhosphorylationPhosphoric Monoester HydrolasesTranscription Factor CHOPUbiquinoneApoptosis Regulatory ProteinsCox4i1 protein, mouseElectron Transport Complex IVGlutaminePhosphoric Monoester HydrolasesTIGAR protein, mouseTranscription Factor CHOPUbiquinoneubiquinone 9COQ9COX4DDIT3/CHOPelectron transfer chainglutamine deprivationglycolysis

Identifiers

PMID34105294
PMCPMC8188220
OpenAlexW3146145140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.